Dapagliflozin, Spironolactone or Both for HFpEF
Condition: Heart Failure With Preserved Ejection Fraction Interventions: Drug: Dapagliflozin; Drug: Spironolactone; Drug: Spironolactone + Dapagliflozin Sponsors: Universidade do Porto; FMUP; Centro Hospitalar Universitário de São João, E.P.E.; Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials